Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics in ovarian stimulation - current concepts and future options.

Reproductive biomedicine online - 1 Nov 2005

Greb Robert R, Behre Hermann M, Simoni Manuela

Abstract excerpt

Tailoring ovarian stimulation to the individual patient can be challenging because the ovarian response varies substantially between patients. Pharmacogenetics has emerged as a new area of research to improve the balance between desired and undesired actions of drugs, based upon the genetic predisposition of the individual patient. Clinical studies have demonstrated that the p.N680S polymorphism of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dose-Response Relationship, Drug
Share to Follicle Stimulating Hormone
Share to Forecasting

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infertility, Female

Share to Ovulation Induction

Share to Pharmacogenetics

Share to Receptors, FSH

Share to Serine

Source

Identifiers

PMID: 16409708
DOI: 10.1016/s1472-6483(10)61167-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics in ovarian stimulation - current concepts and future options.PMID 16409708Read ↗

Pharmacogenetics in ovarian stimulation--current concepts.Semantic proximity Read ↗

Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers.Semantic proximity Read ↗

The Effect of the Allelics of Ser680Asn Polymorphisms of Follicle-Stimulating Hormone Receptor Gene in IVF/ICSI Cycles: a Systematic Review and Meta-analysis.Semantic proximity Read ↗

Pharmacogenetics of FSH Action in the FemaleSemantic proximity Read ↗

Genetic profile of SNP(s) and ovulation induction.Semantic proximity Read ↗

Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation.Semantic proximity Read ↗

Pharmacogenetics of G-protein-coupled receptors variants: FSH receptor and infertility treatment.Semantic proximity Read ↗

Polymorphism of the FSH receptor and ovarian response to FSH.Semantic proximity Read ↗

Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis.Semantic proximity Read ↗

Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype.Semantic proximity Read ↗

The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.Semantic proximity Read ↗

Luteal phase stimulation in double ovarian stimulation cycles is not affected by the follicle-stimulating hormone (FSH) receptor genotype: double ovarian stimulation is beneficial independently of the genotype at position 680 of the follicle-stimulating hormone receptor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.